Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.
- Status
- COMPLETED
- Phase
- NA
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Relatlimab in Combination With Nivolumab in Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
- Status
- COMPLETED
- Phase
- PHASE1
A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy
- Status
- COMPLETED
- Phase
- N/A
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
- Status
- COMPLETED
- Phase
- N/A
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
- Status
- COMPLETED
- Phase
- N/A